Carlos A Velázquez-Martínez is a Professor at the University of Alberta. He received a B.Sc. at the Faculty of Chemical Sciences, University of Guadalajara, Mexico. He earned his M.Sc. degree at the Faculty of Chemistry, National Autonomous University of Mexico (UNAM), Mexico. He obtained a Ph.D. at the Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta. He completed his postdoctoral training at the National Cancer Institute in Frederick, Maryland, USA. He was an Associate Professor at the University of Alberta from 2014 to 2023. He is a member of the Canadian Society for Chemistry (CSC), the Canadian Society for Pharmaceutical Sciences and the American Chemical Society. He is a Member and Associate Editor of the Mexican Chemical Society (Sociedad Química de México).
Amar Natarajan is the Ruth Branham Professor at the Eppley Institute for Research in Cancer and Allied Diseases and is the co-leader of the Targets, Modulators and Delivery Program, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center (UNMC), Omaha NE. He also holds courtesy appointments in the departments of Genetics, Cell Biology and Anatomy, and Pharmaceutical Sciences at UNMC. He received a B.S. in Chemistry at the Madras Christian College and earned his M.S. in Chemistry at the Indian Institute of Technology, Madras, India. He obtained a Ph.D. in Chemistry at the University of Vermont, Burlington, VT, USA. Following his postdoctoral training at the Harvard Medical School, Cambridge, MA, USA., in 2005, he started his independent career as an assistant professor at the University of Texas Medical Branch, Galveston TX, USA. He moved to the UNMC in 2009 as an associate professor and was promoted to full professor in 2014. His leadership in research and mentoring was recognized by the Research Leadership Award UNMC in 2020. He also served as a Panel member of the Drug Discovery and Pharmacology (DMP) study section at NIH from 2016 to 2020.
Adam R Karpf is a professor at the UNMC Eppley
Institute for Research in Cancer and Allied Diseases and is a member of the
Fred and Pamela Buffett Cancer Center at UNMC. He received a B.S. at the
University of South Florida, Tampa. He earned a Ph.D. in virology at
the University of Texas at Austin in 1997 and completed his postdoctoral
training at the Huntsman Cancer Institute at the University of Utah in Salt
Lake City in 2002. He has held faculty positions at the University of Utah, the
Roswell Park Cancer Institute in Buffalo, NY, and UNMC, which he joined in
2012. He won the Springer Nature Author Service Award in 2022 and the UNMC
Distinguished Scientist Award in 2013. He is an expert in ovarian cancer
biology and therapy, and his research centers on investigating new
molecular targets and therapeutic approaches for the treatment of ovarian
cancer.
